B.sub.2 adrenegic agonists and use thereof in the treatment of glaucoma
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 24, 1994
Grant Date -
N/A
app pub date -
Apr 19, 1993
filing date -
Apr 19, 1993
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Compounds having beta-2 adrenergic agonist activity and the use of these compounds in controlling intraocular pressure are disclosed. The compounds are believed to be useful in controlling intraocular pressure by increasing the outflow of aqueous humor. The compounds are considered to be less likely to cause cardiovascular side effects and various other side effects associated with stimulation of beta-1 receptors, relative to epinephrine.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully